Mesh Bio raises US$1.8M seed to help doctors predict diseases before they occur

Mesh Bio, a Singaporean health-tech startup, has raised US$1.8 million in a seed funding round, led by deep-tech investor Elev8.vc and SEEDS capital. Wealth management firm Citrine Capital as well as Singaporean VC firm Tael Partners also joined the round.  Mesh Bio intends to use the capital to accelerate the rollout of its solution, DARA, for healthcare providers in Southeast…
« Previous post: | Next post: »